The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth.
Anthony J PeaseEmily CallanderElla ZomerMary B AbrahamElizabeth A DavisTimothy W JonesDanny LiewSophia ZoungasPublished in: Diabetes care (2022)
In this first cost-effectiveness analysis of HCL technologies for the management of young people with type 1 diabetes, HCL therapy was found to be cost-effective compared with current care in Australia.